{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T22:48:19Z","timestamp":1793486899287,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tamoxifen (TAM) inducible Cre recombinase system is an essential tool to study gene function when early ablation or overexpression can cause developmental defects or embryonic lethality. However, there remains a lack of consensus on the optimal route and dosage of TAM administration in vivo. Here, we assessed dosage and delivery of TAM for activation of Cre in immune cell subsets assessed longitudinally and spatially using transgenic mice with ubiquitously expressed Cre\/ER and the Cre-inducible fluorescent reporter YFP. After comparing two TAM delivery methods (intraperitoneal versus oral gavage) and different doses, we found that 3\u00a0mg of TAM administered orally for five consecutive days provides maximal reporter induction with minimal adverse effects in vivo. Serum levels of TAM peaked 1\u00a0week after initiating treatment then slowly decreased, regardless of dosing and delivery methods. TAM concentration in specific tissues (liver, spleen, lymph nodes, and thymus) was also dependent on delivery method and dose. Cre induction was highest in myeloid cells and B cells and substantially lower in T cells, and double-positive thymocytes had a notably higher response to TAM. In addition to establishing optimal dose and administration of TAM, our study reveals a disparate activity of Cre in different cell immune populations when using Cre\/ER models.<\/jats:p>","DOI":"10.1038\/s41598-020-72179-0","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T17:28:45Z","timestamp":1600363725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Optimization of tamoxifen-induced Cre activity and its effect on immune cell populations"],"prefix":"10.1038","volume":"10","author":[{"given":"Rachel S.","family":"Donocoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nato","family":"Teteloshvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsoo","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rivka","family":"Shoulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi J.","family":"Creusot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"72179_CR1","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1093\/nar\/27.22.4324","volume":"27","author":"AK Indra","year":"1999","unstructured":"Indra, A. K. et al. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: Comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res. 27, 4324\u20134327. https:\/\/doi.org\/10.1093\/nar\/27.22.4324 (1999).","journal-title":"Nucleic Acids Res."},{"key":"72179_CR2","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/nar\/26.6.1427","volume":"26","author":"F Schwenk","year":"1998","unstructured":"Schwenk, F., Kuhn, R., Angrand, P. O., Rajewsky, K. & Stewart, A. F. Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res. 26, 1427\u20131432. https:\/\/doi.org\/10.1093\/nar\/26.6.1427 (1998).","journal-title":"Nucleic Acids Res."},{"key":"72179_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/dbio.2002.0597","volume":"244","author":"S Hayashi","year":"2002","unstructured":"Hayashi, S. & McMahon, A. P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: A tool for temporally regulated gene activation\/inactivation in the mouse. Dev. Biol. 244, 305\u2013318. https:\/\/doi.org\/10.1006\/dbio.2002.0597 (2002).","journal-title":"Dev. Biol."},{"key":"72179_CR4","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1038\/s41598-018-24085-9","volume":"8","author":"HM Jahn","year":"2018","unstructured":"Jahn, H. M. et al. Refined protocols of tamoxifen injection for inducible DNA recombination in mouse astroglia. Sci. Rep. 8, 5913. https:\/\/doi.org\/10.1038\/s41598-018-24085-9 (2018).","journal-title":"Sci. Rep."},{"key":"72179_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0006-2952(96)00650-8","volume":"53","author":"HK Crewe","year":"1997","unstructured":"Crewe, H. K., Ellis, S. W., Lennard, M. S. & Tucker, G. T. Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes. Biochem. Pharmacol. 53, 171\u2013178. https:\/\/doi.org\/10.1016\/S0006-2952(96)00650-8 (1997).","journal-title":"Biochem. Pharmacol."},{"key":"72179_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1124\/dmd.30.8.869","volume":"30","author":"HK Crewe","year":"2002","unstructured":"Crewe, H. K., Notley, L. M., Wunsch, R. M., Lennard, M. S. & Gillam, E. M. J. Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: Formation of the 4-hydroxy, 4\u2019-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen. Drug Metab. Dispos. 30, 869\u2013874. https:\/\/doi.org\/10.1124\/dmd.30.8.869 (2002).","journal-title":"Drug Metab. Dispos."},{"key":"72179_CR7","first-page":"36","volume":"19","author":"SP Robinson","year":"1991","unstructured":"Robinson, S. P., Langan-Fahey, S. M., Johnson, D. A. & Jordan, V. C. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab. Dispos 19, 36\u201343 (1991).","journal-title":"Drug Metab. Dispos"},{"key":"72179_CR8","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1124\/jpet.110.178301","volume":"337","author":"D Iusuf","year":"2011","unstructured":"Iusuf, D. et al. P-glycoprotein (ABCB1) transports the primary active tamoxifen metabolites endoxifen and 4-hydroxytamoxifen and restricts their brain penetration. J. Pharmacol. Exp. Ther. 337, 710\u2013717. https:\/\/doi.org\/10.1124\/jpet.110.178301 (2011).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"72179_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0958-1669(00)00127-0","volume":"11","author":"C Gorman","year":"2000","unstructured":"Gorman, C. & Bullock, C. Site-specific gene targeting for gene expression in eukaryotes. Curr. Opin. Biotechnol. 11, 455\u2013460. https:\/\/doi.org\/10.1016\/S0958-1669(00)00127-0 (2000).","journal-title":"Curr. Opin. Biotechnol."},{"key":"72179_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/(Sici)1526-968x(200002)26:2<99::Aid-Gene1>3.3.Co;2-2","volume":"26","author":"A Nagy","year":"2000","unstructured":"Nagy, A. Cre recombinase: The universal reagent for genome tailoring. Genesis 26, 99\u2013109. https:\/\/doi.org\/10.1002\/(Sici)1526-968x(200002)26:2%3c99::Aid-Gene1%3e3.3.Co;2-2 (2000).","journal-title":"Genesis"},{"key":"72179_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1101\/gad.13.2.142","volume":"13","author":"J Rossant","year":"1999","unstructured":"Rossant, J. & McMahon, A. \u201cCre\u201d-ating mouse mutants\u2014A meeting review on conditional mouse genetics. Gene Dev. 13, 142\u2013145. https:\/\/doi.org\/10.1101\/gad.13.2.142 (1999).","journal-title":"Gene Dev."},{"key":"72179_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/gene.10021","volume":"32","author":"C Guo","year":"2002","unstructured":"Guo, C., Yang, W. & Lobe, C. G. A Cre recombinase transgene with mosaic, widespread tamoxifen-inducible action. Genesis 32, 8\u201318 (2002).","journal-title":"Genesis"},{"key":"72179_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1182\/blood.V97.1.324","volume":"97","author":"XH Mao","year":"2001","unstructured":"Mao, X. H., Fujiwara, Y., Chapdelaine, A., Yang, H. D. & Orkin, S. H. Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood 97, 324\u2013326. https:\/\/doi.org\/10.1182\/blood.V97.1.324 (2001).","journal-title":"Blood"},{"key":"72179_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-213x-1-4","volume":"1","author":"S Srinivas","year":"2001","unstructured":"Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. Bmc Dev. Biol. 1, 4. https:\/\/doi.org\/10.1186\/1471-213x-1-4 (2001).","journal-title":"Bmc Dev. Biol."},{"key":"72179_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s12033-014-9738-0","volume":"56","author":"M Sakaguchi","year":"2014","unstructured":"Sakaguchi, M. et al. Dramatic increase in expression of a transgene by insertion of promoters downstream of the cargo gene. Mol. Biotechnol. 56, 621\u2013630. https:\/\/doi.org\/10.1007\/s12033-014-9738-0 (2014).","journal-title":"Mol. Biotechnol."},{"key":"72179_CR16","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1038\/s41467-019-10239-4","volume":"10","author":"M Fernandez-Chacon","year":"2019","unstructured":"Fernandez-Chacon, M. et al. iSuRe-Cre is a genetic tool to reliably induce and report Cre-dependent genetic modifications. Nat. Commun. 10, 2262. https:\/\/doi.org\/10.1038\/s41467-019-10239-4 (2019).","journal-title":"Nat. Commun."},{"key":"72179_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5625\/lar.2018.34.4.147","volume":"34","author":"H Kim","year":"2018","unstructured":"Kim, H., Kim, M., Im, S. K. & Fang, S. Mouse Cre-LoxP system: General principles to determine tissue-specific roles of target genes. Lab. Anim. Res. 34, 147\u2013159. https:\/\/doi.org\/10.5625\/lar.2018.34.4.147 (2018).","journal-title":"Lab. Anim. Res."},{"key":"72179_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/0471142735.im1034s105","volume":"105","author":"S Sharma","year":"2014","unstructured":"Sharma, S. & Zhu, J. Immunologic applications of conditional gene modification technology in the mouse. Curr. Protoc. Immunol. 105, 11\u201313. https:\/\/doi.org\/10.1002\/0471142735.im1034s105 (2014).","journal-title":"Curr. Protoc. Immunol."},{"key":"72179_CR19","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/immu.200310005","volume":"33","author":"J de Boer","year":"2003","unstructured":"de Boer, J. et al. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33, 314\u2013325. https:\/\/doi.org\/10.1002\/immu.200310005 (2003).","journal-title":"Eur. J. Immunol."},{"key":"72179_CR20","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s11248-009-9342-4","volume":"19","author":"KB Andersson","year":"2010","unstructured":"Andersson, K. B., Winer, L. H., Mork, H. K., Molkentin, J. D. & Jaisser, F. Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts. Transgenic Res. 19, 715\u2013725. https:\/\/doi.org\/10.1007\/s11248-009-9342-4 (2010).","journal-title":"Transgenic Res."},{"key":"72179_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.bone.2015.07.034","volume":"81","author":"ZA Zhong","year":"2015","unstructured":"Zhong, Z. A. et al. Optimizing tamoxifen-inducible Cre\/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice. Bone 81, 614\u2013619. https:\/\/doi.org\/10.1016\/j.bone.2015.07.034 (2015).","journal-title":"Bone"},{"key":"72179_CR22","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/dvg.22417","volume":"51","author":"IM Pimeisl","year":"2013","unstructured":"Pimeisl, I. M. et al. Generation and characterization of a tamoxifen-inducible Eomes(CreER) mouse line. Genesis 51, 725\u2013733. https:\/\/doi.org\/10.1002\/dvg.22417 (2013).","journal-title":"Genesis"},{"key":"72179_CR23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/dvg.20569","volume":"47","author":"D Baup","year":"2009","unstructured":"Baup, D., Moser, M., Schurmans, S. & Leo, O. Developmental regulation of the composite CAG promoter activity in the murine T lymphocyte cell lineage. Genesis 47, 799\u2013804. https:\/\/doi.org\/10.1002\/dvg.20569 (2009).","journal-title":"Genesis"},{"key":"72179_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/0192623310386499","volume":"38","author":"B Thoolen","year":"2010","unstructured":"Thoolen, B. et al. Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol. Pathol. 38, 5\u201381. https:\/\/doi.org\/10.1177\/0192623310386499 (2010).","journal-title":"Toxicol. Pathol."},{"key":"72179_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/01926230590522428","volume":"33","author":"JM Cullen","year":"2005","unstructured":"Cullen, J. M. Mechanistic classification of liver injury. Toxicol. Pathol. 33, 6\u20138. https:\/\/doi.org\/10.1080\/01926230590522428 (2005).","journal-title":"Toxicol. Pathol."},{"key":"72179_CR26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/dvg.22052","volume":"50","author":"K Aghajani","year":"2012","unstructured":"Aghajani, K., Keerthivasan, S., Yu, Y. & Gounari, F. Generation of CD4CreER(T2) transgenic mice to study development of peripheral CD4-T-cells. Genesis 50, 908\u2013913. https:\/\/doi.org\/10.1002\/dvg.22052 (2012).","journal-title":"Genesis"},{"key":"72179_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/978-1-59745-471-1_18","volume":"530","author":"S Feil","year":"2009","unstructured":"Feil, S., Valtcheva, N. & Feil, R. Inducible Cre mice. Methods Mol. Biol. 530, 343\u2013363. https:\/\/doi.org\/10.1007\/978-1-59745-471-1_18 (2009).","journal-title":"Methods Mol. Biol."},{"key":"72179_CR28","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1093\/nar\/gkw405","volume":"44","author":"G P\u00e9pin","year":"2016","unstructured":"P\u00e9pin, G. et al. Cre-dependent DNA recombination activates a STING-dependent innate immune response. Nucleic Acids Res. 44, 5356\u20135364. https:\/\/doi.org\/10.1093\/nar\/gkw405 (2016).","journal-title":"Nucleic Acids Res."},{"key":"72179_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7095-7_19","volume":"1623","author":"S Le Gallou","year":"2017","unstructured":"Le Gallou, S., Nojima, T., Kitamura, D., Weill, J. C. & Reynaud, C. A. The AID-Cre-ERT2 model: A tool for monitoring B cell immune responses and generating selective hybridomas. Methods Mol. Biol. 1623, 243\u2013251. https:\/\/doi.org\/10.1007\/978-1-4939-7095-7_19 (2017).","journal-title":"Methods Mol. Biol."},{"key":"72179_CR30","first-page":"779","volume":"56","author":"JS Hubbard","year":"2017","unstructured":"Hubbard, J. S., Chen, P. H. & Boyd, K. L. Effects of repeated intraperitoneal injection of pharmaceutical-grade and nonpharmaceutical-grade corn oil in female C57BL\/6J Mice. J. Am. Assoc. Lab. Anim. Sci. 56, 779\u2013785 (2017).","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"72179_CR31","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/jat.3442","volume":"37","author":"K Saito","year":"2017","unstructured":"Saito, K. et al. Arachidonic acid-containing phosphatidylcholine characterized by consolidated plasma and liver lipidomics as an early onset marker for tamoxifen-induced hepatic phospholipidosis. J. Appl. Toxicol. 37, 943\u2013953. https:\/\/doi.org\/10.1002\/jat.3442 (2017).","journal-title":"J. Appl. Toxicol."},{"key":"72179_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0899-9007(00)00513-x","volume":"17","author":"M Takeda","year":"2001","unstructured":"Takeda, M., Imaizumi, M., Sawano, S., Manabe, Y. & Fushiki, T. Long-term optional ingestion of corn oil induces excessive caloric intake and obesity in mice. Nutrition 17, 117\u2013120. https:\/\/doi.org\/10.1016\/s0899-9007(00)00513-x (2001).","journal-title":"Nutrition"},{"key":"72179_CR33","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/hep.23813","volume":"52","author":"LK Cole","year":"2010","unstructured":"Cole, L. K., Jacobs, R. L. & Vance, D. E. Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis. Hepatology 52, 1258\u20131265. https:\/\/doi.org\/10.1002\/hep.23813 (2010).","journal-title":"Hepatology"},{"key":"72179_CR34","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1242\/dmm.010447","volume":"6","author":"K Bersell","year":"2013","unstructured":"Bersell, K. et al. Moderate and high amounts of tamoxifen in \u03b1MHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death. Dis. Model Mech. 6, 1459\u20131469. https:\/\/doi.org\/10.1242\/dmm.010447 (2013).","journal-title":"Dis. Model Mech."},{"key":"72179_CR35","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1101\/pdb.prot077966","volume":"269\u2013271","author":"J Whitfield","year":"2015","unstructured":"Whitfield, J., Littlewood, T. & Soucek, L. Tamoxifen administration to mice. Cold Spring Harb. Protoc. 269\u2013271, 2015. https:\/\/doi.org\/10.1101\/pdb.prot077966 (2015).","journal-title":"Cold Spring Harb. Protoc."},{"key":"72179_CR36","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/sj.mt.6300251","volume":"15","author":"S Hong","year":"2007","unstructured":"Hong, S. et al. Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells. Mol. Ther. 15, 1630\u20131639. https:\/\/doi.org\/10.1038\/sj.mt.6300251 (2007).","journal-title":"Mol. Ther."},{"key":"72179_CR37","doi-asserted-by":"publisher","first-page":"e54009","DOI":"10.1371\/journal.pone.0054009","volume":"8","author":"M Takiguchi","year":"2013","unstructured":"Takiguchi, M. et al. Variability of inducible expression across the hematopoietic system of tetracycline transactivator transgenic mice. PLoS ONE 8, e54009. https:\/\/doi.org\/10.1371\/journal.pone.0054009 (2013).","journal-title":"PLoS ONE"},{"key":"72179_CR38","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1002\/jcph.771","volume":"56","author":"JL Powers","year":"2016","unstructured":"Powers, J. L. et al. Multigene and drug interaction approach for tamoxifen metabolite patterns reveals possible involvement of CYP2C9, CYP2C19, and ABCB1. J. Clin. Pharmacol. 56, 1570\u20131581. https:\/\/doi.org\/10.1002\/jcph.771 (2016).","journal-title":"J. Clin. Pharmacol."},{"key":"72179_CR39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2019.09.009","volume":"51","author":"B Reizis","year":"2019","unstructured":"Reizis, B. The specificity of conditional gene targeting: A case for Cre reporters. Immunity 51, 593\u2013594. https:\/\/doi.org\/10.1016\/j.immuni.2019.09.009 (2019).","journal-title":"Immunity"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72179-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T14:46:34Z","timestamp":1670337994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72179-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72179"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72179-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"6 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15244"}}